BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 34125319)

  • 21. The Vaginal Microbiome: IV. The Role of Vaginal Microbiome in Reproduction and in Gynecologic Cancers.
    Ventolini G; Vieira-Baptista P; De Seta F; Verstraelen H; Lonnee-Hoffmann R; Lev-Sagie A
    J Low Genit Tract Dis; 2022 Jan; 26(1):93-98. PubMed ID: 34928259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic Review: The Impact of Cancer Treatment on the Gut and Vaginal Microbiome in Women With a Gynecological Malignancy.
    Muls A; Andreyev J; Lalondrelle S; Taylor A; Norton C; Hart A
    Int J Gynecol Cancer; 2017 Sep; 27(7):1550-1559. PubMed ID: 28590950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uterine microbiome-low biomass and high expectations†.
    Garcia-Grau I; Simon C; Moreno I
    Biol Reprod; 2019 Dec; 101(6):1102-1114. PubMed ID: 30544156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of the female genital tract and gut microbiome on reproductive dysfunction.
    Cao W; Fu X; Zhou J; Qi Q; Ye F; Li L; Wang L
    Biosci Trends; 2024 Jan; 17(6):458-474. PubMed ID: 38104979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora.
    Sadrekarimi H; Gardanova ZR; Bakhshesh M; Ebrahimzadeh F; Yaseri AF; Thangavelu L; Hasanpoor Z; Zadeh FA; Kahrizi MS
    J Transl Med; 2022 Jul; 20(1):301. PubMed ID: 35794566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in the Vaginal Microbiome and Associated Toxicities Following Radiation Therapy for Gynecologic Cancers.
    Tsementzi D; Meador R; Eng T; Patel P; Shelton J; Arluck J; Scott I; Dolan M; Khanna N; Konstantinidis KT; Bruner DW
    Front Cell Infect Microbiol; 2021; 11():680038. PubMed ID: 34778097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Oncobiome in Gastroenteric and Genitourinary Cancers.
    D'Antonio DL; Marchetti S; Pignatelli P; Piattelli A; Curia MC
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Female Gut and Genital Tract Microbiota-Induced Crosstalk and Differential Effects of Short-Chain Fatty Acids on Immune Sequelae.
    Amabebe E; Anumba DOC
    Front Immunol; 2020; 11():2184. PubMed ID: 33013918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging pathogenic links between microbiota and the gut-lung axis.
    Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
    Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Gut Microbiome in Pancreatic Disease.
    Akshintala VS; Talukdar R; Singh VK; Goggins M
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):290-295. PubMed ID: 30144522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and evaluation of the microbiome in the female and male reproductive tracts.
    Koedooder R; Mackens S; Budding A; Fares D; Blockeel C; Laven J; Schoenmakers S
    Hum Reprod Update; 2019 May; 25(3):298-325. PubMed ID: 30938752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Interplay Between Reproductive Tract Microbiota and Immunological System in Human Reproduction.
    Al-Nasiry S; Ambrosino E; Schlaepfer M; Morré SA; Wieten L; Voncken JW; Spinelli M; Mueller M; Kramer BW
    Front Immunol; 2020; 11():378. PubMed ID: 32231664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical Cancer.
    Sims TT; Colbert LE; Klopp AH
    J Immunother Precis Oncol; 2021 May; 4(2):72-78. PubMed ID: 35663536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiome Regulation of Autoimmune, Gut and Liver Associated Diseases.
    Singh B; Qin N; Reid G
    Inflamm Allergy Drug Targets; 2015; 14(2):84-93. PubMed ID: 26817477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential contribution of the uterine microbiome in the development of endometrial cancer.
    Walther-António MR; Chen J; Multinu F; Hokenstad A; Distad TJ; Cheek EH; Keeney GL; Creedon DJ; Nelson H; Mariani A; Chia N
    Genome Med; 2016 Nov; 8(1):122. PubMed ID: 27884207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
    Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
    Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of the Gut Microbiome in Hypertension.
    Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
    Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
    [No Abstract]   [Full Text] [Related]  

  • 38. The Role of Microbiota in the Immunopathogenesis of Endometrial Cancer.
    Sobstyl M; Brecht P; Sobstyl A; Mertowska P; Grywalska E
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease.
    Cho JA; Chinnapen DJF
    J Microbiol; 2018 Mar; 56(3):183-188. PubMed ID: 29492875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies.
    Macke L; Schulz C; Koletzko L; Malfertheiner P
    Aliment Pharmacol Ther; 2020 Mar; 51(5):505-526. PubMed ID: 31990420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.